| Literature DB >> 33799479 |
Katharina Juraschek1, Maria Borowiak2, Simon H Tausch2, Burkhard Malorny2, Annemarie Käsbohrer1,3, Saria Otani4, Stefan Schwarz5, Diana Meemken6, Carlus Deneke2, Jens Andre Hammerl1.
Abstract
Antimicrobial resistance (AMR) is a major threat to public health worldwide. Currently, AMR typing changes from phenotypic testing to whole-genome sequence (WGS)-based detection of resistance determinants for a better understanding of the isolate diversity and elements involved in gene transmission (e.g., plasmids, bacteriophages, transposons). However, the use of WGS data in monitoring purposes requires suitable techniques, standardized parameters and approved guidelines for reliable AMR gene detection and prediction of their association with mobile genetic elements (plasmids). In this study, different sequencing and assembly strategies were tested for their suitability in AMR monitoring in Escherichia coli in the routines of the German National Reference Laboratory for Antimicrobial Resistances. To assess the outcomes of the different approaches, results from in silico predictions were compared with conventional phenotypic- and genotypic-typing data. With the focus on (fluoro)quinolone-resistant E.coli, five qnrS-positive isolates with multiple extrachromosomal elements were subjected to WGS with NextSeq (Illumina), PacBio (Pacific BioSciences) and ONT (Oxford Nanopore) for in depth characterization of the qnrS1-carrying plasmids. Raw reads from short- and long-read sequencing were assembled individually by Unicycler or Flye or a combination of both (hybrid assembly). The generated contigs were subjected to bioinformatics analysis. Based on the generated data, assembly of long-read sequences are error prone and can yield in a loss of small plasmid genomes. In contrast, short-read sequencing was shown to be insufficient for the prediction of a linkage of AMR genes (e.g., qnrS1) to specific plasmid sequences. Furthermore, short-read sequencing failed to detect certain duplications and was unsuitable for genome finishing. Overall, the hybrid assembly led to the most comprehensive typing results, especially in predicting associations of AMR genes and mobile genetic elements. Thus, the use of different sequencing technologies and hybrid assemblies currently represents the best approach for reliable AMR typing and risk assessment.Entities:
Keywords: AMR; hybrid assembly; long-read sequencing; mobile genetic elements; qnrS; short-read sequencing
Year: 2021 PMID: 33799479 PMCID: PMC8000739 DOI: 10.3390/microorganisms9030598
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Overview on basic information of the E. coli isolates, including their antimicrobial resistance profile and the size of extrachromosomal elements.
| Isolate ID | Matrix | Date of Isolation | AMR Profile | Sizes of Identified Plasmids + |
|---|---|---|---|---|
| 17-AB00050 | cecum, broiler | 22 November 2016 | AMP, CEF, CIP, FOT, GEN, SMX, TAZ | 174 kb; 100 kb; 90 kb; 45 kb *; <20.5 kb |
| 17-AB00090 | feces, turkey | 14 December 2016 | AMP, CIP, NAL, TET | 100 kb *; 65 kb; 53 kb; <20.5 kb |
| 17-AB00432 | cecum, calf | 21 February 2017 | AMP, CEF, CIP, FOT, NAL, TAZ, TET, TMP, SMX | 95 kb * |
| 17-AB00587 | meat, bovine | 23 March 2017 | AMP, CEF, CIP, FOT, TAZ | 115 kb; 100 kb *; 30 kb |
| 17-AB00639 | cecum, pig | 24 April 2017 | AMP, CEF, CIP, FOT, GEN, SMX, TAZ, TMP | 140 kb; 100 kb; 95 kb; 45 kb *; <20.5 kb |
Abbreviations: AMP: ampicillin, AZI: azithromycin, CEF: cefepime, FOT: cefotaxime, FOX: cefoxitin, TAZ: ceftazidime, CHL: chloramphenicol, CIP: ciprofloxacin, COL: colistin, GEN: gentamicin, NAL: nalidixic acid, SMX: sulfamethoxazole, TET: tetracycline, TGC: tigecycline, TMP: trimethoprim; *: plasmid carrying qnrS, identified by S1-PFGE analysis; +: data was obtained from S1-PFGE analysis and DNA-DNA hybridization.
Characteristics of contigs detected with different sequencing and assembly strategies in five E. coli isolates. Circularized contigs are presented in bold.
| 17-AB00050 | 17-AB00090 | 17-AB00432 | 17-AB00587 | 17-AB00639 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Contigs (Plasmidal Content Relative to Total Contig Length) | Number of Circular Contigs/All Contigs < 10 kb | Longest Contig [bp] | Number of Contigs (Plasmidal Content Relative to Total Contig Length) | Number of Circular Contigs/Contigs < 10 kb | Longest Contig [bp] | Number of Contigs (Plasmidal Content Relative to Total Contig Length) | Number of Circular Contigs/Contigs < 10 kb | Longest Contig [bp] | Number of Contigs (Plasmidal Content Relative to Total Contig Length) | Number of Circular Contigs/Contigs < 10 kb | Longest Contig [bp] | Number of Contigs (Plasmidal Content Relative to Total Contig Length) | Number of Circular Contigs/Contigs < 10 kb | Longest Contig [bp] | |
|
| 466 (5.5%) | 2/2 | 341,211 | 186 (4.3%) | 3/3 | 502,527 | 159 (1.6%) | 0/0 | 314,433 | 201 (4.2%) | 0/0 | 485,939 | 183 (7.6%) | 2/2 | 340,946 |
|
| 13 (4.6%) | 4/1 | 4094,393 | 6 (4.6%) | 6/2 |
| 2 (2.1%) | 2/0 |
| 3 (4.4%) | 3/0 |
| 7 (7.9%) | 4/1 | 3,693,252 |
|
| 8 (5.3%) | 7/0 |
| 5 (4.6%) | 5/0 |
| 3 (2.7%) | 3/0 |
| 3 (4.4%) | 3/0 |
| 7 (8.3%) | 7/4 |
|
|
| 27 (4.2%) | 6/2 | 4,341,057 | 7 (4.6%) | 7/3 |
| 3 (2.4%) | 3/0 |
| 3 (4.4%) | 3/0 |
| 13 (8.1%) | 7/2 |
|
|
| 22 (4.0%) | 6/2 |
| 7 (4.6%) | 7/3 |
| 3 (2.4%) | 3/0 |
| 3 (4.4%) | 3/0 |
| 9 (8.2%) | 9/2 |
|
Figure 1Distribution of plasmid size, detected with different sequencing and assembly approaches. A black dot represents a determined closed plasmid at the respective size for the given method. A green dot represents the size of the plasmid, detected in the laboratory with S1-PFGE.
Figure 2Plasmid composition of extrachromosomal elements carrying the qnrS1 gene. (A): 17-AB00050 (B): 17-AB00090 (C): 17-AB00432 (D): 17-AB00587 (E): 17-AB00639. Illustrations were generated from hybrid assembly with BRIG (v0.95). Red elements represent the resistance genes. Green colored rings represent the isolates plasmid. Yellow colored rings represent the reference plasmid (annotation of plasmids are available in Supplement S6).
Characteristics of contigs detected with different sequencing and assembly strategies in five E. coli isolates harboring the qnrS1 gene. Circularized contigs are presented in bold.
| 17-AB00050 | 17-AB00090 | 17-AB00432 | 17-AB00587 | 17-AB00639 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Contig Size [bp] | Plasmid Marker | Other AMR Genes | Contig Size [bp] | lPlasmid Marker | Other AMR Genes | Contig Size [bp] | Plasmid Marker | Other AMR Genes | Contig Size [bp] | Plasmid Marker | Other AMR Genes | Contig Size [bp] | Plasmid Marker | Other AMR Genes | |
|
| 42,601 | IncX3 | - | 5348 | - | - | 13,373 | - | - | 1762 | - | - | 8821 | - | - |
|
|
| IncX3 |
|
| IncI1_1_α |
|
| IncY |
| IncI1_1α |
| IncX1, IncX3 |
| ||
|
|
| IncX3 |
|
| IncI1_1_α |
|
| IncY |
| IncI1_1α |
| IncX1, IncX3 |
| ||
|
|
| IncX3 |
|
| IncI1_1_α |
|
| IncY |
| IncI1_1α |
| IncX1 |
| ||
|
|
| IncX3 |
|
| IncI1_1_ α |
|
| IncY |
| IncI1_1α |
| IncX1 |
| ||
|
| 45,000 | 100,000 | 95,000 | 100,000 | 45,000 | ||||||||||
|
| no | yes | no | yes | yes | ||||||||||
Abbreviation: AMR, antimicrobial resistance.
Antimicrobial resistance phenotype and resistance determinants predicted with various assembly and sequencing techniques in five E. coli isolates.
|
| ||||
|
|
|
|
|
|
| Quinolone | Quinolone |
| Ciprofloxacin | Fluoroquinolone |
| β-Lactam | Penicillin, Cephalosporin | Ampicillin | β-Lactam | |
| Cefepime | Cephalosporin | |||
| Cefotaxime | Cephalosporin | |||
| Aminoglycoside | Gentamicin |
| Gentamicin | Aminoglycoside |
| Sulfonamide | Sulfonamid |
| Sulphamethoxazole | Sulfonamide |
| Aminoglycoside | Streptomycin |
| Not within the test panel | Not within the test panel |
|
| ||||
|
|
|
|
|
|
| β-Lactam | Penicillin | Ampicillin | β-Lactam | |
| β-Lactam | Penicillin, Cephalosporine |
| ||
| Quinolone | Quinolone |
| Ciprofloxacin | Fluoroquinolone |
| Nalidixic acid | Quinolone | |||
| Tetracycline | Tetracycline | Tetracycline | Tetracycline | |
|
| ||||
|
|
|
|
|
|
| β-Lactam | Penicillin |
| Ampicillin | β-Lactam |
| β-Lactam | Penicillin, Cephalosporin | Cefepime | Cephalosporin | |
| Cefotaxime | Cephalosporin | |||
| Ceftazidime | Cephalosporin | |||
| Aminoglycoside | Kanamycin |
| Not within the test panel | Not within the test panel |
| Quinolone | Quinolone |
| Ciprofloxacin | Fluoroquinolone |
| Nalidixic acid | Quinolone | |||
| Aminoglycoside | Streptomycin | Not within the test panel | Not within the test panel | |
|
| ||||
| Sulfonamide | Sulfonamide | Sulphamethoxazole | Sulfonamide | |
| Tetracycline | Tetracycline | Tetracycline | Tetracycline | |
|
| ||||
|
|
|
|
|
|
| β-Lactam | Cephalosporin | Cefepime | Cephalosporin | |
| Cefotaxime | Cephalosporin | |||
| Ceftazidime | Cephalosporin | |||
| Lincosamide | Lincosamide | Not within the test panel | Not within the test panel | |
| Macrolide | Macrolide | |||
| Quinolone | Fluoroquinolone |
| Ciprofloxacin | Fluoroquinolone |
| Aminoglycoside | Streptomycin | Not within the test panel | Not within the test panel | |
|
| ||||
|
|
|
|
|
|
| β-Lactam | Penicillin |
| Ampicillin | β-Lactam |
| β-Lactam | Penicillin, Cephalosporin*3 | Cefepime | Cephalosporin | |
| Cefotaxime | Cephalosporine | |||
| Ceftazidime | Cephalosporine | |||
| Aminoglycoside | Gentamicin | Gentamicin | Aminoglycoside | |
| Aminoglycoside | Hygromicin | Not within the test panel | Not within the test panel | |
| Macrolide | Macrolide | |||
| Quinolone | Fluoroquinolone |
| Ciprofloxacin | Fluoroquinolon |
| Aminoglycoside | Streptomycin | Not within the test panel | Not within the test panel | |
|
| ||||
| Sulfonamide | Sulfonamide |
| Sulphamethoxazole | Sulfonamide |
| Diaminopyrimidine | Trimethoprim |
| Trimethoprim | Diaminopyrimidine |
*1: duplication detected in all long-read and hybrid assemblies but not in NextSeq assemblies. *2: gene only determined with data Flye-ONT assemblies. *3: duplication detected in all long-read and hybrid assemblies but not in short-read-only assemblies. *4: detected in all long-read and hybrid assemblies but not in NextSeq assemblies. *5: not detected in short-read-only assemblies and Flye-ONT sequences.